Bacteriostatic Antibiotics Market to Witness Steady Growth Rate During 2018 to 2026

Bacteriostatic Antibiotics Market to Witness Steady Growth Rate to 2026 Including Global Top Players Allergan Plc., Pfizer Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Akorn Inc., Tetraphase Pharmaceuticals, Inc.

Antibiotics are naturally occurring or artificially produced substances, which are widely used in the treatment of bacterial diseases. Antibiotics works by killing bacteria (bactericidal effect) or by inhibiting their growth (bacteriostatic effect). Although bacteriostatic antibiotics prevent bacterial growth and reproduction, it does not necessarily kill them.

Ask For Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2307

Bacteriostatic Antibiotics Market Drivers

Global bacteriostatic antibiotics market is expected to witness a significant growth over the forecast period, owing to recent approval and launch of novel bacteriostatic antibiotics products in the market. For instance, in September 2018, Tetraphase Pharmaceuticals, Inc., a biopharmaceutical company dedicated to development, manufacturing, and commercialization of novel antibiotics for treat life-threatening multidrug-resistant (MDR) infections received European Commission (EC) marketing authorization for its novel bacteriostatic antibiotic namely XERAVA (eravacycline) injection, which is indicated for the treatment of complicated intra-abdominal infections (cIAI) in adults in the European Union. XERAVA (Eravacycline) is a fluorocycline antibacterial within the tetracycline class of antibacterial drugs, it is bacteriostatic against gram-positive bacteria (e.g., Staphylococcus aureus and Enterococcus faecalis).

Bacteriostatic Antibiotics Market Regional Analysis

North America bacteriostatic antibiotics market is expected to hold a dominant position in the global Bacteriostatic Antibiotics Market and account for largest market share over the forecast period, owing to presence of key players and approval and launch of novel bacteriostatic antibiotics drugs by them in the region. For instance, in August 2018, Tetraphase Pharmaceuticals, Inc., a Massachusetts, U.S-based biopharmaceutical company, received the U.S. Food and Drug Administration (FDA) approval for its novel bacteriostatic antibiotics namely XERAVA (eravacycline) for the treatment of complicated intra-abdominal infections (cIAI)

Bacteriostatic Antibiotics Market Key Players

Key players operating in global Bacteriostatic Antibiotics Market include

1. Tetraphase Pharmaceuticals, Inc.

2. Allergan Plc.

3. Pfizer Inc.

4. Mylan N.V.

5. Sun Pharmaceutical Industries Ltd.

6. Hikma Pharmaceuticals Plc.

7. Akorn Inc., and Others

Bacteriostatic Antibiotics Market Taxonomy:

The global bacteriostatic antibiotics market is segmented on the basis of indication, age group, dosage form, distribution channel, and region

By Type -

• Tetracycline
• Doxycycline
• Chloramphenicol
• Erythromycin
• Fusidic acid
• Sulfonamides
• Trimethoprim
• Macrolides
• Lincosamides
• Others

By Age Group -

• Pediatric
• Adults

By Dosage Form -

• Tablet
• Capsule
• Injectables

By Distribution Channel -

• Hospitals Pharmacies
• Retail Pharmacies
• Online pharmacies

By Region -

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa

Browse Full Report @ https://www.coherentmarketinsights.com/ongoing-insight/bacteriostatic-antibiotics-market-2307

Also, Coherent Market Insights has a proprietary database of pipeline biologics and biosimilars, called PHASE-XS. This database provides analytical data in addition to the clinical information of ongoing trials for biologics and biosimilars. An amalgamation of more than 30 parameters, PHASE-XS helps biotechnology and pharmaceutical companies to analyze the market trend, competition, and market potential. For more information or to access this database, kindly click on the below link or contact at sales@coherentmarketinsights.com

https://www.coherentmarketinsights.com/phase-xs/

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com